Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FYBVL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,670
Award facts
- Contract value 100% obligated
- $18,669.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,669.96 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on October 23, 2025, with completion expected by October 24, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. RINVOQ is a Janus kinase inhibitor used in the treatment of rheumatoid arthritis and other inflammatory conditions, supporting the pharmaceutical supply needs of military and federal healthcare systems.
This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen serves as a critical distributor for the Defense Health Agency and other federal healthcare systems, providing a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's role as a major pharmaceutical vendor reflects its consistent capability to meet federal procurement requirements through open competition and support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FYBVL?
SPE2DB26FYBVL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FYBVL worth?
The government has obligated $18,670 on SPE2DB26FYBVL.
Is contract SPE2DB26FYBVL an order under another contract?
Yes. SPE2DB26FYBVL is a delivery order under SPE2DB20D3505, an indefinite delivery contract.
Was contract SPE2DB26FYBVL competed?
The extent of competition for SPE2DB26FYBVL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award